Key Takeaways
- • TPG Capital has emerged as the frontrunner to acquire a majority stake in Everlight Radiology, a British-Australian teleradiology provider valued at approximately £525 million, with the sale process expected to conclude around mid-2026 through Morgan Stanley and Allier Capital.
- • TPG passed on acquiring Qscan Group, a $1 billion diagnostic imaging business, citing superior earnings growth prospects elsewhere in the healthcare sector—signaling selective deal discipline despite active portfolio building in medical services.
- • Everlight Radiology is currently owned by Livingbridge, which acquired the business in 2021 for over $335 million; the asset has appreciated substantially, reflecting strong performance in the teleradiology market.
- • TPG's healthcare investment activity remains robust, with recent acquisitions including Lifestance Health ($1.2 billion equity investment in April 2026, subsequently taken public) and OneOncology (majority stake acquired with AmerisourceBergen taking minority interest), demonstrating aggressive consolidation in specialist medical services.
Summary
TPG Capital has positioned itself as the lead bidder for Everlight Radiology, a teleradiology platform with significant operations across the United Kingdom and Australia. The business is being marketed by Livingbridge, the current owner, which acquired Everlight approximately three years ago (2021) for more than $335 million. The asset is now valued at roughly £525 million, reflecting material appreciation. Morgan Stanley and Allier Capital are managing the sale process, with transaction closure expected around mid-2026. Australian private equity firm BGH Capital has also been examining the opportunity, indicating competitive tension in the bidding process.
The transaction represents TPG's continued focus on healthcare services consolidation, particularly in higher-margin specialist and ancillary care segments. The firm's recent deal activity underscores this strategic priority: in April 2026, TPG acquired Lifestance Health for $1.2 billion in equity (the company subsequently completed an initial public offering), and the firm has secured majority stakes in OneOncology in partnership with AmerisourceBergen. This healthcare concentration follows TPG's decision to pass on Qscan Group, the $1 billion Australian diagnostic imaging business, suggesting the firm applies disciplined capital allocation based on earnings growth potential rather than transaction size alone.
Everlight's teleradiology model—leveraging remote diagnostic capabilities across multiple jurisdictions—aligns with TPG's thesis on scalable, technology-enabled healthcare services. The business operates in an attractive market characterized by structural demand for radiology services and capacity constraints in traditional imaging delivery models. A TPG acquisition would likely accelerate geographic expansion and technology investment, consistent with the firm's typical playbook in specialist healthcare services. The transaction is expected to close during the second half of 2026.
The transaction represents TPG's continued focus on healthcare services consolidation, particularly in higher-margin specialist and ancillary care segments. The firm's recent deal activity underscores this strategic priority: in April 2026, TPG acquired Lifestance Health for $1.2 billion in equity (the company subsequently completed an initial public offering), and the firm has secured majority stakes in OneOncology in partnership with AmerisourceBergen. This healthcare concentration follows TPG's decision to pass on Qscan Group, the $1 billion Australian diagnostic imaging business, suggesting the firm applies disciplined capital allocation based on earnings growth potential rather than transaction size alone.
Everlight's teleradiology model—leveraging remote diagnostic capabilities across multiple jurisdictions—aligns with TPG's thesis on scalable, technology-enabled healthcare services. The business operates in an attractive market characterized by structural demand for radiology services and capacity constraints in traditional imaging delivery models. A TPG acquisition would likely accelerate geographic expansion and technology investment, consistent with the firm's typical playbook in specialist healthcare services. The transaction is expected to close during the second half of 2026.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.